Navigation Links
Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21, 2009
Date:8/31/2009

NASHVILLE, Tenn., Aug. 31 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Chief Executive Officer A.J. Kazimi will present at the UBS Global Life Sciences Conference in New York at 11:00 a.m. Eastern Time on Monday, September 21, 2009. Mr. Kazimi will provide an update on the Company and its Caldolor product, which Cumberland is preparing to launch following its recent approval by the Food and Drug Administration.

The presentation will be simultaneously webcast and can be accessed by visiting the Investor Relations section on Cumberland Pharmaceuticals' website at www.cumberlandpharma.com. Shortly following the live webcast, a replay will be available and archived for 30 days.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland markets Acetadote(R) for the treatment of acetaminophen poisoning and Kristalose(R), a prescription laxative. The Company also recently received FDA approval for Caldolor(R), the first injectable treatment for pain and fever available in the United States. Cumberland is dedicated to providing innovative products which improve quality of care for patients. The Company recently completed an initial public offering of its common stock.

For more information on Cumberland Pharmaceuticals, please visit '/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Orion ICG, LLC Announces Acquisition of Cumberland Therapy Services, Inc.
2. Cumberland Pharmaceuticals Announces Appointments
3. Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
4. Cumberland Pharmaceuticals Reports Second Quarter 2009 Financial Results
5. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
10. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... (PRWEB) May 25, 2013 An experienced ... page in partnership with JD Media Surge, LLC. ... are now available and, depending on the treatment, can ... a routine visit, the best method will be chosen ... performed during a visit. A special peroxide-based whitening gel ...
(Date:5/25/2013)... (HealthDay News) -- Many viruses and parasites that affect ... -- a bacteria-borne illness than can result in liver ... parks, according to a veterinarian. These germs ... the air, said Dr. Susan Nelson, a clinical associate ... of these serious diseases can be fatal, even with ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Providing patients with ... Diet Doc team of weight management professionals. But, aside from ... and effectively, Diet Doc’s hCG diets also provide ... abuse during childhood like bullying, more control over their lives ... of dealing with the underlying factors of weight gain derived ...
(Date:5/25/2013)... By working diligently for months on this ... the 2012 Lamborghini Aventador into their well-built fitments database. ... the list of vehicles lined by SizeItUp for the ... to thrill automobile lovers in the year 2013. ... the 2012 Lamborghini Aventador comes with extraordinarily spacious cabin ...
(Date:5/25/2013)... 25, 2013 According to world-renowned scholars, ... and powerful women that ever lived. Cleopatra’s legendary beauty ... of the most powerful men in her time. Cleopatra ... to keep her skin glowing and fresh, from her ... wax, maringa oil and cyprus grass. , Cleopatra was ...
Breaking Medicine News(10 mins):Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Hidden Dangers Dog Dog Parks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
... stem cells to become fat cells, study finds , , TUESDAY, ... theory that obesity may stem, a least in part, from ... fat cells. , The roots of obesity are probably complex ... showed that exposure to adenovirus-36 (Ad-36), which causes respiratory and ...
... pregnancy-data support WHO recommendations , In an observational ... and colleagues report on prevention of mother-to-child HIV ... World Health Organization recommendations., Citation: Tonwe-Gold B, Ekouevi ... al. (2007) Antiretroviral treatment and prevention of peripartum ...
... WHO recommendations , In an observational cohort ... colleagues report on prevention of mother-to-child HIV transmission ... Health Organization recommendations. , Citation: Tonwe-Gold B, Ekouevi ... al. (2007) Antiretroviral treatment and prevention of peripartum ...
... seriously ill patients have to travel by ambulance to ... die, reveals research in Emergency Medicine Journal. , People ... the study indicates. , The findings have implications for ... departments in favour of fewer more specialised centres, in ...
... with organ transplants, resigned to a lifetime of anti-rejection ... respite, say researchers at Lucile Packard Children,s Hospital and ... blood sample, the scientists have identified for the first ... small group of patients who beat the odds and ...
... Calif. - People with organ transplants, resigned to a ... hope for a respite, say researchers at Lucile Packard ... Using a simple blood sample, the scientists have identified ... shared by a small group of patients who beat ...
Cached Medicine News:Health News:Virus Could Help Drive Obesity 2Health News:Virus Could Help Drive Obesity 3Health News:Consequences of online HIV denial; and more 2Health News:Consequences of online HIV denial; and more 3Health News:Consequences of online HIV denial; and more 4Health News:HIV therapy in pregnancy-data support WHO recommendations 2Health News:Longer ambulance journeys boost death risk for seriously ill patients 2Health News:Study provides hope that some transplant patients could live free of anti-rejection drugs 2Health News:Study provides hope that some transplant patients could live free of anti-rejection drugs 3Health News:Study provides hope that some transplant patients could live free of antirejection drugs 2Health News:Study provides hope that some transplant patients could live free of antirejection drugs 3
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... 23, 2013  MGC Diagnostics Corporation (NASDAQ: ... company, today scheduled a conference call to discuss its ... 2013, ended April 30, 2013. The call will be ... The Company will report financial results for the second ... on Thursday, May 30, 2013. (Logo: ...
(Date:5/23/2013)... , May 23, 2013 More than ... may not benefit from chemotherapy and still have excellent ... launch of one of the largest sources of online ... website and interactive Facebook page provide recently diagnosed women ... can safely avoid chemotherapy. "We anticipate these ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
... Banner Health ... MASI ) today jointly announce Banner Health,s system-wide ... that patients visiting any Banner Health hospital will be cared ... patient monitoring solutions available.   "The decision to ...
... Company (NYSE:  KVa/KVb) announced today that it has received ... that the Company has reestablished compliance with the NYSE,s ... accelerated basis. The NYSE,s notification confirmed that ... Stock for the 30-trading days ended August 31, 2010, ...
Cached Medicine Technology:Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology 2Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology 3Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology 4Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology 5Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology 6K-V Pharmaceutical Company Receives Notification From New York Stock Exchange of Compliance With Quantitative Continued Listing Standards 2K-V Pharmaceutical Company Receives Notification From New York Stock Exchange of Compliance With Quantitative Continued Listing Standards 3K-V Pharmaceutical Company Receives Notification From New York Stock Exchange of Compliance With Quantitative Continued Listing Standards 4K-V Pharmaceutical Company Receives Notification From New York Stock Exchange of Compliance With Quantitative Continued Listing Standards 5K-V Pharmaceutical Company Receives Notification From New York Stock Exchange of Compliance With Quantitative Continued Listing Standards 6K-V Pharmaceutical Company Receives Notification From New York Stock Exchange of Compliance With Quantitative Continued Listing Standards 7K-V Pharmaceutical Company Receives Notification From New York Stock Exchange of Compliance With Quantitative Continued Listing Standards 8
... oximeters available, Datex-Ohmeda s TuffSat is the ... transport, and EMS. TuffSat comes fully loaded ... index measurement) a quick, easy-to-use clinical ... perfusion at the sensor site. Now you ...
... clinical information. , ,S/5 Clinical Communications ... solutions that help you and your care ... You will have access to essential patient ... with your care team and specialists, independent ...
... safe and easy patient monitoring during MRI, ... special needs of the MRI environment. It allows ... MRI, promoting safety and flexibility., ,Though designed ... all the key benefits of the S/5 Monitoring ...
... and comprehensive solution for advanced arrhythmia ... (ARRWS) provides one compact, PC-based solution ... patients. It connects to Datex-Ohmeda Network ... up to 16 beds., ,The ...
Medicine Products: